ConductScience.org, home

Trial · NCT01168908

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Double Blind, Placebo ControlledSTARTEDRevatio (Sildenafil)10
Double Blind, Placebo ControlledSTARTEDPlacebo10
Double Blind, Placebo ControlledCOMPLETEDRevatio (Sildenafil)7
Double Blind, Placebo ControlledCOMPLETEDPlacebo8
Double Blind, Placebo ControlledNOT COMPLETEDRevatio (Sildenafil)3
Double Blind, Placebo ControlledNOT COMPLETEDPlacebo2
Open LabelSTARTEDRevatio (Sildenafil)7
Open LabelSTARTEDPlacebo8
Open LabelCOMPLETEDRevatio (Sildenafil)6
Open LabelCOMPLETEDPlacebo7
Open LabelNOT COMPLETEDRevatio (Sildenafil)1
Open LabelNOT COMPLETEDPlacebo1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01168908/flow